Skip to content

Mitochondrial Dna Depletion Syndrome 9 C3151476

Published: July 22, 2026Updated: August 20, 2026

A rare genetic mitochondrial disease with severe energy production defects affecting multiple body systems. Presents with developmental delay and organ dysfunction. Management is supportive.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(neurologic)

Hypotonia

(neurologic)

Hearing loss

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Coenzyme Q10 and Mitochondrial Cofactor Supplementation

Supplementation with CoQ10, L-carnitine, and other mitochondrial cofactors may support electron transport chain function and improve energy production in affected tissues.

medication
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Disease Progression Surveillance

Regular neurological examinations, imaging studies, and laboratory monitoring to track disease progression and adjust management strategies accordingly.

monitoring

Additional treatment options

Metabolic Diet Optimization

Nutritional support designed to reduce metabolic stress on mitochondria through balanced macronutrient intake and adequate hydration.

dietary

Neuromuscular Rehabilitation

Therapeutic exercises and interventions targeting muscle weakness, fatigue management, and preservation of functional independence.

physical_therapy

Experimental Therapeutic Approaches

Participation in clinical trials evaluating novel therapies targeting mitochondrial DNA maintenance and replication pathways.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mitochondrial Dna Depletion Syndrome 9 C3151476?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Mitochondrial Dna Depletion Syndrome 9 C3151476. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy